Clinical Features and Management of COVID-19–Associated Hypercoagulability

COVID-19 is an acute respiratory disease of viral origin caused by SARS-CoV-2. This disease is associated with a hypercoagulable state resulting in arterial and venous thrombotic events. The latter are more frequent, especially in patients who develop a severe form of the disease and are associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Massaro, Gianluca, Lecis, Dalgisio, Martuscelli, Eugenio, Chiricolo, Gaetano, Sangiorgi, Giuseppe Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556574/
https://www.ncbi.nlm.nih.gov/pubmed/35221084
http://dx.doi.org/10.1016/j.ccep.2021.10.005
Descripción
Sumario:COVID-19 is an acute respiratory disease of viral origin caused by SARS-CoV-2. This disease is associated with a hypercoagulable state resulting in arterial and venous thrombotic events. The latter are more frequent, especially in patients who develop a severe form of the disease and are associated with an increased mortality rate. It is therefore essential to identify patients at higher risk to initiate antithrombotic therapy. Hospitalized patients treated with treatment dose of anticoagulants had better outcomes than those treated with prophylactic dose. However, several trials are ongoing to better define the therapeutic and prevention strategies for this insidious complication.

Ejemplares similares